The liraglutide-treated group also had significantly ( p0 .03 ) lower day-long glucose ( -8.2 % [ -11 , -6 ] vs -0.1 [ -3 , 2 ] ) and NEFA concentrations ( -14 [ -20 , -8 ] vs -2.1 [ -10 , 6 ] ) following mixed meals , whereas day-long insulin concentrations did not significantly differ as compared with placebo .